IFNL2 and infection: To confirm whether exogenous addition of type I (IFN-β1) or type III (IFN-λ2/3) IFNs can prevent rotavirus infection, human intestinal epithelial cells were treated with increasing concentrations of either IFN for 16 h prior to infection.